Read this commentary covering recent gynecologic cancer clinical trial updates and new key data for advanced ovarian endometrial and cervical cancer presented at the 2024 ESMO congress including expert thoughts and clinical implications for practicechanging results in endometrial and cervical cancer
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/oncology/gyn-cancer-updates-esmo-2024/24481-55615
- Start Date: 2024-10-10 05:00:00
- End Date: 2024-10-10 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.25 hours
- Commercial Support: Source: AstraZeneca (Any division) - Amount: 31666.67 - Is Kind Support: False Source: Merck (Any division) - Amount: 20000.0 - Is Kind Support: False Source: Seagen - Amount: 10000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest